GPR52-MODULATORVERBINDUNGEN

Patent europeic · EP4401833 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4401833
Numer da la dumonda
EP22778038
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
15-09-2022
Publitgà
24-07-2024
Concedì
22-10-2025
La protecziun finescha il pli tard
14-09-2042
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
A61P 25/00 (2006.01)
C07D 401/04 (2006.01)
C07F 9/09 (2006.01)
A61K 31/4439 (2006.01)
Prioritad
GB 202113186 15.09.2021
Dumonda PCT
PCT/GB2022/052328 15.09.2022
Publicaziun PCT
WO2023/041909 23.03.2023
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 02-09-2026

    Midada

    Published in Swissreg on 02.09.2026

  3. 24-10-2025

    Represchentant inscrit

    Representative
    Bovard SA, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 24.10.2025

  4. 22-10-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.10.2025

Partidas

Possessur

Nxera Pharma UK Limited

Granta Park Great Abington, Cambridge, Cambridgeshire CB21 6DG, GB

Represchentant

Bovard AG

Bovard SA

Optingenstrasse 16, 3013 Bern

Inventur

WATSON, Stephen Paul

Cambridge Cambridgeshire CB21 6DG, GB

SWAIN, Nigel Alan

Cambridge Cambridgeshire CB21 6DG, GB

O'BRIEN, Michael Alistair

Cambridge Cambridgeshire CB21 6DG, GB

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.